BioCryst has also filed its line extension application for the use of ORLADEYO oral granules in patients with HAE aged 2 to 11 years with the European Medicines Agency. Additional regulatory filings ...

A Houston-based nonprofit is investing in biomanufacturing startups, which use renewable products like corn or seaweed in ...

Bio Usawa, a private biotech company focused on boosting drug access in Africa, inked a deal with cleanroom and laboratory ...

MIT today launched its Initiative for New Manufacturing (INM), an Institute-wide effort to reinfuse U.S. industrial ...

Job cuts at home-grown pharma companies like Arvinas and RallyBio and federal policies challenge CT biotech 'ecosystem' that ...

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

A team of drug, strategy, and manufacturing pros are on board to fast-track Nuvec® and power up its commercial game ...

Samsung Biologics, the biopharmaceutical arm of Samsung Group, said on May 26 it had secured two contract manufacturing deals ...

The global Healthcare Contract Manufacturing Market size is projected to be valued at USD 183.7 billion in 2023 and reach USD 347.5 billion by 2030, growing ...

GenScript, a global leader in life science research tools and services support, has expanded its mRNA synthesis and ...

Indian CDMOs are strategically expanding through acquisitions in the US and Europe, driven by global pharma's nearshoring ...

Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the "Company” or "Zhengye”), a veterinary vaccine manufacturer that ...